← ANALYSTS · TIPRANKS
Robert Burns · H.C. Wainwright
Hits
52%
258 of 496 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+25.9%
Over a year after the rating, TipRanks’ measure
Our companies rated now
31
Buy / hold / sell: 25 / 5 / 1
Upside of the analyst’s targets
+282.6%
Average over 26 current targets, to the last price
The market’s answer to the ratings
+6.1%
Day-0 move against SPY in the rating’s direction, average over 17 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 16on TipRanks 06:25 | NRIXIWMNurix Therapeutics · $2.7B | Reiterated | Buy | $34.00 → $36.00+5.9% | +47.4% | −1.0% | ↗ |
| Oct 13on TipRanks 12:35 | PRLDIWMPrelude Therapeutics · $258M | Reiterated | Buy | $8.00 | +145.4% | −4.8%next day −8.2% | ↗ |
| Oct 13on TipRanks 06:26 | AVBPIWMArriVent BioPharma, Inc. · $828M | Reiterated | Buy | $27.00 | +62.1% | −2.2%next day +1.8% | ↗ |
| Oct 8on TipRanks 06:25 | AVBPIWMArriVent BioPharma, Inc. · $828M | Reiterated | Buy | $47.00 → $27.00−42.6% | +62.1% | −0.6%next day −0.5% · 5 days +0.8% | ↗ |
| Oct 8on TipRanks 06:20 | CRBUIWMCaribou Biosciences · $50M | Downgrade | Hold | — | — | −21.6%next day −5.0% · 5 days −3.3% | ↗ |
| Oct 2on TipRanks 07:07 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | $35.00 | +170.7% | +6.0%next day +2.7% · 5 days −1.0% | ↗ |
| Sep 30on TipRanks 06:25 | TLXTelix Pharmaceuticals Limited Unsponsored ADR · $3.8B | Reiterated | Buy | $20.00 | +87.1% | −3.1%next day −2.5% · 5 days −0.5% | ↗ |
| Sep 25on TipRanks 06:40 | CGEMIWMCullinan Management · $901M | Reiterated | Buy | $30.00 → $35.00+16.7% | +170.7% | −4.6%next day +1.7% · 5 days +4.9% | ↗ |
| Sep 16on TipRanks Sep 15 08:50 | COGTIWMCogent Biosciences · $4.9B | Reiterated | Buy | $55.00 | +86.3% | −1.5%next day −0.2% · 5 days −2.7% | ↗ |
| Sep 9on TipRanks 07:25 | INBXIWMInhibrx Biosciences Inc · $1.3B | Reiterated | Buy | $245 | +172.7% | −0.8%next day −0.7% · 5 days −8.7% | ↗ |
| Aug 27on TipRanks 06:15 | RVMDRevolution Medicines · $41.5B | Reiterated | Buy | $195 → $280+43.6% | +57.3% | +2.0%next day −5.8% · 5 days −4.9% | ↗ |
| Aug 26on TipRanks 06:16 | ZYMEIWMZymeworks · $1.8B | Reiterated | Buy | $51.00 → $55.00+7.8% | +119.7% | +6.7%next day −1.7% · 5 days +6.1% | ↗ |
| Aug 21on TipRanks Aug 20 06:16 | RLAYIWMRelay Therapeutics · $3.8B | Reiterated | Buy | $28.00 → $29.00+3.6% | +78.1% | −4.2%next day −1.7% · 5 days −2.5% | ↗ |
| Aug 21on TipRanks Aug 18 06:25 | ELTXIWMElicio Therapeutics · $48M | Reiterated | Buy | $23.00 | +1,374.4% | +3.7%next day +0.4% · 5 days −3.0% | ↗ |
| Aug 18on TipRanks 06:30 | TNGXIWMTango Therapeutics · $3.8B | Reiterated | Buy | $66.00 → $68.00+3.0% | +208.5% | +1.3%next day −1.2% · 5 days −2.4% | ↗ |
| Aug 17on TipRanks 06:31 | AVBPIWMArriVent BioPharma, Inc. · $828M | Reiterated | Buy | $47.00 | +182.1% | −1.2%next day +4.1% · 5 days −1.4% | ↗ |
| Aug 10on TipRanks 06:30 | ORICIWMOric Pharmaceuticals · $1.3B | Reiterated | Buy | $25.00 → $27.00+8.0% | +118.6% | +0.9%next day +1.1% · 5 days −1.7% | ↗ |
| Aug 10on TipRanks 06:27 | IMMXIWMImmix Biopharma · $720M | Reiterated | Buy | $20.00 → $25.00+25.0% | +213.3% | +4.2%next day +13.7% · 5 days +12.0% | ↗ |
| Aug 7on TipRanks 07:06 | NUVBIWMNuvation Bio · $1.7B | Reiterated | Buy | $21.00 | +371.9% | +7.4%next day 0.0% · 5 days −6.2% | ↗ |
| Aug 6on TipRanks 06:45 | BDTXIWMBlack Diamond Therapeutics · $100M | Reiterated | Buy | $11.00 | +539.5% | +7.4%next day +1.0% · 5 days +4.0% | ↗ |
| Jul 31on TipRanks 06:38 | KPTIIWMKaryopharm Therapeutics · $7M | Downgrade | Hold | $13.00 → $3.00−76.9% | +669.2% | −73.3%next day +1.2% · 5 days +6.9% | ↗ |
| Jul 29on TipRanks 06:39 | PRLDIWMPrelude Therapeutics · $258M | Reiterated | Buy | $8.00 | +145.4% | +3.0%next day +5.5% · 5 days −9.1% | ↗ |
| Jul 20on TipRanks Jul 23 21:14 | OKURIWMOnKure Therapeutics · $91M | Reiterated | Buy | $27.00 → $21.00−22.2% | +900.0% | −1.7%next day +0.4% · 5 days −1.3% | ↗ |
| Jul 10on TipRanks 06:10 | NRIXIWMNurix Therapeutics · $2.7B | Reiterated | Buy | $32.00 → $34.00+6.2% | +39.2% | −7.0%next day −0.8% · 5 days +1.8% | ↗ |
| Jul 9on TipRanks 11:26 | FATEFate Therapeutics · $278M | Reiterated | Buy | $7.00 | +291.1% | +5.3%next day −0.8% · 5 days −12.1% | ↗ |
| Jul 9on TipRanks 06:15 | ELVNIWMEnliven Therapeutics · $2.9B | Reiterated | Buy | $56.00 → $65.00+16.1% | +74.2% | +1.9%next day −2.5% · 5 days −2.4% | ↗ |
| Jul 2on TipRanks 06:30 | EXELExelixis · $14.8B | Reiterated | Buy | $56.00 | −10.0% | +3.6%next day −1.4% · 5 days −0.2% | ↗ |
| Jun 16on TipRanks 06:15 | CRBUIWMCaribou Biosciences · $50M | Reiterated | Buy | $11.00 | +2,245.4% | +2.4%next day −1.7% · 5 days +0.3% | ↗ |
| Jun 8on TipRanks 06:15 | ADCTIWMADC Therapeutics · $190M | Downgrade | Hold | — | — | −5.4%next day +12.9% · 5 days +5.4% | ↗ |
| Jun 3on TipRanks Jun 2 11:50 | AKTSIWMAktis Oncology, Inc. · $890M | Assigned | Buy | $35.00 | +132.4% | +3.9%next day −3.7% · 5 days −3.4% | ↗ |
| Jun 1on TipRanks 06:50 | BCAXIWMBicara Therapeutics Inc. · $1.2B | Reiterated | Buy | $42.00 | +150.3% | −5.5%next day −4.9% · 5 days 0.0% | ↗ |
| Jun 1on TipRanks 06:30 | CATXIWMPerspective Therapeutics · $267M | Reiterated | Buy | $13.00 | +499.1% | −7.4%next day −1.8% · 5 days −17.4% | ↗ |
| May 7on TipRanks 06:30 | MGNXIWMMacroGenics · $211M | Reiterated | Hold | — | — | −2.0%next day +1.2% · 5 days +39.2% | ↗ |
| Apr 27on TipRanks 06:25 | BNTXBioNTech SE · $24.1B | Reiterated | Buy | $130 | +48.2% | −3.4%next day +0.5% · 5 days −3.1% | ↗ |
| Apr 21on TipRanks 06:25 | WHWKIWMWhitehawk Therapeutics · $173M | Reiterated | Hold | — | — | −0.1%next day −0.3% · 5 days −2.7% | ↗ |
| Apr 16on TipRanks Apr 14 06:20 | ALLOIWMAllogene Therapeutics · $463M | Reiterated | Buy | $12.00 → $11.00−8.3% | +739.7% | −26.7%next day −5.6% · 5 days +0.4% | ↗ |
| Apr 13on TipRanks 06:15 | REPLIWMReplimune Group · $1.1B | Downgrade | Sell | — | — | −65.3%next day +13.5% · 5 days +18.5% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗